122 related articles for article (PubMed ID: 20403349)
21. Bistable switch in migration stimulating factor expression: regulation by the concerted signalling of transforming growth factor-β1 and the extracellular matrix.
Schor SL; Ellis IR; Jones SJ; Woolston AM; Schor AM
Int J Cancer; 2012 May; 130(9):2024-32. PubMed ID: 21630266
[TBL] [Abstract][Full Text] [Related]
22. Implications for collagen binding from the crystallographic structure of fibronectin 6FnI1-2FnII7FnI.
Erat MC; Schwarz-Linek U; Pickford AR; Farndale RW; Campbell ID; Vakonakis I
J Biol Chem; 2010 Oct; 285(44):33764-70. PubMed ID: 20739283
[TBL] [Abstract][Full Text] [Related]
23. Metabolic remodeling of the tumor microenvironment: migration stimulating factor (MSF) reprograms myofibroblasts toward lactate production, fueling anabolic tumor growth.
Carito V; Bonuccelli G; Martinez-Outschoorn UE; Whitaker-Menezes D; Caroleo MC; Cione E; Howell A; Pestell RG; Lisanti MP; Sotgia F
Cell Cycle; 2012 Sep; 11(18):3403-14. PubMed ID: 22918248
[TBL] [Abstract][Full Text] [Related]
24. Migration-stimulating factor (MSF) is over-expressed in non-small cell lung cancer and promotes cell migration and invasion in A549 cells over-expressing MSF.
Deng X; Ma Q; Zhang B; Jiang H; Zhang Z; Wang Y
Exp Cell Res; 2013 Oct; 319(17):2545-53. PubMed ID: 23791940
[TBL] [Abstract][Full Text] [Related]
25. Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts.
Grey AM; Schor AM; Rushton G; Ellis I; Schor SL
Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2438-42. PubMed ID: 2488545
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of an IGD peptidomimetic with motogenic activity.
Shpiro N; Ellis IR; Dines TJ; Schor AM; Schor SL; Norman DG; Marquez R
Mol Biosyst; 2005 Oct; 1(4):318-20. PubMed ID: 16880997
[TBL] [Abstract][Full Text] [Related]
27. Migration-stimulating factor as a novel biomarker in salivary gland tumours.
Aljorani LE; Bankfalvi A; Carey FA; Harada K; Ohe G; Jones SJ; Ellis IR; Schor SL; Schor AM
J Oral Pathol Med; 2011 Nov; 40(10):747-54. PubMed ID: 21481007
[TBL] [Abstract][Full Text] [Related]
28. Modulation of cell-adhesive activity of fibronectin by the alternatively spliced EDA segment.
Manabe R; Ohe N; Maeda T; Fukuda T; Sekiguchi K
J Cell Biol; 1997 Oct; 139(1):295-307. PubMed ID: 9314547
[TBL] [Abstract][Full Text] [Related]
29. Endothelial cell interactions with synthetic peptides from the carboxyl-terminal heparin-binding domains of fibronectin.
Huebsch JC; McCarthy JB; Diglio CA; Mooradian DL
Circ Res; 1995 Jul; 77(1):43-53. PubMed ID: 7788881
[TBL] [Abstract][Full Text] [Related]
30. Mechanism of action of the migration stimulating factor produced by fetal and cancer patient fibroblasts: effect on hyaluronic and synthesis.
Schor SL; Schor AM; Grey AM; Chen J; Rushton G; Grant ME; Ellis I
In Vitro Cell Dev Biol; 1989 Aug; 25(8):737-46. PubMed ID: 2768134
[TBL] [Abstract][Full Text] [Related]
31. Enhanced integrin mediated signaling and cell cycle progression on fibronectin mimetic peptide amphiphile monolayers.
Shroff K; Pearce TR; Kokkoli E
Langmuir; 2012 Jan; 28(3):1858-65. PubMed ID: 22149259
[TBL] [Abstract][Full Text] [Related]
32. Bivalent ligation of the collagen-binding modules of fibronectin by SFS, a non-anchored bacterial protein of Streptococcus equi.
Ma W; Ma H; Fogerty FJ; Mosher DF
J Biol Chem; 2015 Feb; 290(8):4866-4876. PubMed ID: 25525266
[TBL] [Abstract][Full Text] [Related]
33. Structural analysis of collagen type I interactions with human fibronectin reveals a cooperative binding mode.
Erat MC; Sladek B; Campbell ID; Vakonakis I
J Biol Chem; 2013 Jun; 288(24):17441-50. PubMed ID: 23653354
[TBL] [Abstract][Full Text] [Related]
34. Phenotypic and genetic alterations in mammary stroma: implications for tumour progression.
Schor SL; Schor AM
Breast Cancer Res; 2001; 3(6):373-9. PubMed ID: 11737888
[TBL] [Abstract][Full Text] [Related]
35. Angiogenesis and tumour progression: migration-stimulating factor as a novel target for clinical intervention.
Schor AM; Schor SL
Eye (Lond); 2010 Mar; 24(3):450-8. PubMed ID: 20019766
[TBL] [Abstract][Full Text] [Related]
36. Characterization of FN-C/H-V, a novel synthetic peptide from fibronectin that promotes rabbit corneal epithelial cell adhesion, spreading, and motility.
Mooradian DL; McCarthy JB; Skubitz AP; Cameron JD; Furcht LT
Invest Ophthalmol Vis Sci; 1993 Jan; 34(1):153-64. PubMed ID: 8425821
[TBL] [Abstract][Full Text] [Related]
37. Purification and characterization of human lung fibroblast motility-stimulating factor for human soft tissue sarcoma cells: identification as an NH2-terminal fragment of human fibronectin.
Hu M; Pollock RE; Nicolson GL
Cancer Res; 1997 Aug; 57(16):3577-84. PubMed ID: 9270031
[TBL] [Abstract][Full Text] [Related]
38. Human peri-tumoral and lung fibroblasts produce paracrine motility factors for recently established human sarcoma cell strains.
Hu M; Pollock RE; Nakamura T; Nicolson GL
Int J Cancer; 1995 Sep; 62(5):585-92. PubMed ID: 7665230
[TBL] [Abstract][Full Text] [Related]
39. Rat plasma fibronectin contains two distinct chemotactic domains for fibroblastic cells.
Fukai F; Suzuki H; Suzuki K; Tsugita A; Katayama T
J Biol Chem; 1991 May; 266(14):8807-13. PubMed ID: 2026595
[TBL] [Abstract][Full Text] [Related]
40. Activated focal adhesion kinase involved in adhesion and migration of vascular smooth muscle cells stimulated by fibronectin.
Yin H; Wang L; Huo Y; Peng X; Xia C; Tang C
Chin Med J (Engl); 2002 Apr; 115(4):494-7. PubMed ID: 12133282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
